Thymidine kinase as a predictor of response to chemotherapy in advanced breast cancer
- 13 Downloads
Cytosols from breast cancers were measured for estrogen receptor (ER) and thymidine kinase (TK) activity. There was no correlation between ER and TK in 137 primary breast cancers studied. The results of TK from 57 metastatic breast cancers were correlated with the response or failure to subsequent hormonal therapy or chemotherapy. TK did not predict the responses to hormonal therapy in 12 patients. Of the 45 patients treated with chemotherapies, 13 of 15 tumors with TK over 80 pmol/mg/min responded (86%), while only 4 of the 30 tumors (13%) with TK below 80 pmol/mg/min responded (p<0.001). TK appears to be useful in predicting the responses to chemotherapy.
Keywordsbreast cancer chemotherapy response prediction thymidine kinase
Unable to display preview. Download preview PDF.
- 1.McGuire WL, Carbone PP, Vollmer EPC (eds): Estrogen Receptors in Human Breast Cancer. Raven Press, New York, 1975Google Scholar
- 2.Salmon SE (ed): Cloning of Human Tumor Stem Cells. Alan R Liss, New York, 1980Google Scholar
- 4.Bronzert DA, Monaco ME, Pinkus L, Aitken S, Lippman ME: Purification and properties of estrogen-responsive cytoplasmic thymidine kinase from human breast cancer. Cancer Res 41:604–610, 1981Google Scholar
- 6.Rajewsky MF: Proliferative parameters relevant to cancer therapy. Recent Results Cancer Res 2:156–171, 1975Google Scholar
- 13.Special report: Steroid receptors in breast cancer. N Engl J Med 301:1011–1012, 1979Google Scholar
- 14.Zhang H-J, Snover D, Kennedy BJ, Kiang DT: Correlation of thymidine kinase activity, histology and steroid receptors in primary breast cancer (Abstract C-29). Proc Am Soc Clin Oncol 1:8, 1982Google Scholar